Discontinued — last reported Q4 '25
Labcorp Holdings Impairment Charges increased by 414.3% to $3.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 28.6%, from $2.80M to $3.60M. Over 3 years (FY 2022 to FY 2025), Impairment Charges shows a downward trend with a -74.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase signals poor past investment decisions or deteriorating market conditions, which is generally viewed negatively by investors.
These are non-cash charges recognized when the carrying value of an asset exceeds its fair market value. Such charges in...
Common in large, diversified firms that frequently acquire or divest business units.
impairment_charges| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $1.20M | $0.00 | $0.00 | $260.50M | $2.20M | $2.80M | $10.20M | $333.80M | $2.50M | $0.00 | $0.00 | $2.80M | $0.00 | $0.00 | $700.00K | $3.60M |
| QoQ Change | — | — | — | -100.0% | — | — | -99.2% | +27.3% | +264.3% | >999% | -99.3% | -100.0% | — | — | -100.0% | — | — | +414.3% |
| YoY Change | — | — | — | — | — | — | +83.3% | — | — | +28.1% | +13.6% | -100.0% | -100.0% | -99.2% | -100.0% | — | — | +28.6% |